# Omeprazole

## OKWE 20mg

##### 

| TAH Drug Code      | [OOKW](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OOKW)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Ulcer of duodenum. Gastroesophageal reflux disease. Gastric ulcer. Erosive esophagitis. Zollinger-Ellison Syndrome                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Dosing             | Peptic or duodenal ulcer: adult, initial 20 mg QD for 2 weeks; if necessary, 20- 40mg QD for another 2 weeks Gastric ulcer & GERD: 20 mg QD for 4 weeks; if necessary, 20- 40mg QD for another 4 weeks Zollinger-Ellison syndrome: Initial, 60 mg QD; may increase up to 120 mg once daily; doses greater than 80 mg/day should be administered in divided doses, and the dose should be individualized for each patient.                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Concomitant use of rilpivirine-containing products. Hypersensitivity to any component of the product or to substituted benzimidazoles; anaphylaxis and acute interstitial nephritis have been reported.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | Common Dermatologic: Rash (2% ) Gastrointestinal: Abdominal pain (5% ), Constipation (2% ), Diarrhea (4% ), Flatulence (3% ), Nausea (4% ), Regurgitation, Acid (2% ), Vomiting (3% ) Neurologic: Asthenia (2% ), Dizziness (2% ), Headache (7% ) Respiratory: Upper respiratory infection (Adult, 2% ) Other: Fever (1 to less than 2 years, 33% ) Serious Dermatologic: Cutaneous lupus erythematosus, Erythema multiforme, Stevens-Johnson syndrome, Toxic epidermal necrolysis Endocrine metabolic: Hypomagnesemia Gastrointestinal: Atrophic gastritis, Clostridium difficile diarrhea, Fundic gland polyposis of stomach, Pancreatitis Hematologic: Hemolytic anemia Hepatic: Hepatic encephalopathy, Hepatic necrosis, Liver failure Immunologic: Anaphylaxis Musculoskeletal: Fracture of bone, Hip fracture, Rhabdomyolysis Renal: Tubulointerstitial nephritis, acute Other: Angioedema |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

